Institute of General Practice, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
Institute of General Practice, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
BMJ Open. 2021 Feb 17;11(2):e037333. doi: 10.1136/bmjopen-2020-037333.
The objective of this study was to find relevant concepts of functioning in community-dwelling older adults within frequently used assessment instruments published in the scientific literature. This was part of a larger project to develop an International Classification of Functioning, Disability and Health (ICF) Core Set for use in primary care.
A scoping review was conducted. Articles dealing with functioning in older adults were searched and assessed for eligibility. The study population included community-dwelling adults (≥75 years) without dementia, living in high-resource countries. Relevant concepts were extracted from assessment instruments and linked to the ICF using standardised linking rules. Finally, a frequency analysis was conducted.
Home, primary care.
Community-dwelling adults aged 75 years and above.
From 5060 identified publications, 68 were included and 30 assessment instruments extracted. Overall, 1182 concepts were retrieved. Most were linked to the 'activities and participation' component. The most frequently identified categories were memory functions', 'dressing' and 'changing basic body position'.
This review provides a list of relevant ICF categories from the research perspective that will be used for developing an ICF Core Set for older primary care patients.
PROSPERO (CRD42017067784), (VfD_17_003833) and ClinicalTrials.gov (NCT03384732).
本研究旨在从科学文献中常用的评估工具中寻找社区居住的老年人群体的相关功能概念。这是为在初级保健中开发国际功能、残疾和健康分类(ICF)核心集而进行的更大项目的一部分。
进行了范围界定审查。搜索并评估了涉及老年人功能的文章,以确定其是否符合条件。研究人群包括居住在高资源国家、无痴呆的社区居住成年人(≥75 岁)。从评估工具中提取相关概念,并使用标准化链接规则将其链接到 ICF。最后,进行了频率分析。
家庭,初级保健。
年龄在 75 岁及以上的社区居住成年人。
从 5060 篇已识别的出版物中,有 68 篇被纳入,30 篇评估工具被提取。总共检索到 1182 个概念。大多数与“活动和参与”部分相关联。最常被识别的类别是“记忆功能”、“穿衣”和“改变基本体位”。
本综述提供了从研究角度出发的与 ICF 相关的类别列表,这些类别将用于为老年初级保健患者开发 ICF 核心集。
PROSPERO(CRD42017067784)、(VfD_17_003833)和 ClinicalTrials.gov(NCT03384732)。